机译:Nkx2-1抑制肺腺癌进展
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,LudwigCenter for Molecular Oncology, Massachusetts Institute of Technology,Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
Dana-Farber Cancer Institute, Harvard University, Cambridge, Massachusetts 02115, USA,Broad Institute,Cambridge, Massachusetts 02142,USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,LudwigCenter for Molecular Oncology, Massachusetts Institute of Technology,Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
Dana-Farber Cancer Institute, Harvard University, Cambridge, Massachusetts 02115, USA,Broad Institute,Cambridge, Massachusetts 02142,USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA;
Department of Biomedical Sciences, Tufts University Veterinary School, North Grafton, Massachusetts 01536, USA;
Dana-Farber Cancer Institute, Harvard University, Cambridge, Massachusetts 02115, USA,Broad Institute,Cambridge, Massachusetts 02142,USA,Department of Genetics, University of North Carolina, North Carolina 27599, USA;
Dana-Farber Cancer Institute, Harvard University, Cambridge, Massachusetts 02115, USA,Broad Institute,Cambridge, Massachusetts 02142,USA;
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,LudwigCenter for Molecular Oncology, Massachusetts Institute of Technology,Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge,Massachusetts 02139, USA;
机译:长期非编码RNA PIK3CD-AS2通过YBX1介导的P53途径抑制肺腺癌进展
机译:NKX2-1介导的顺铂敏感性在肺腺癌中介导的依赖于调节TNFSF10表达的P53突变状态
机译:SelenBP1,直接NKX2-1靶,肺腺癌的肿瘤抑制活性
机译:肺腺原位癌(AIS)的综合分析揭示了肺癌进展的新见解
机译:肺腺癌进展和转移中的肿瘤-细胞外基质相互作用。
机译:肺腺癌进展的抑制由NKX2-1
机译:Nkx2-1抑制肺腺癌的进展